Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | HDFC |
| AUM | ₹3,211 Cr | ₹3,128 Cr |
| NAV | ₹53.4879 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 3.1 years |
| Expense ratio | 0.9% | 1.1% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 94.70 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | — | +12.97% |
| 3 months | — | +7.13% |
| 6 months | — | +17.84% |
| YTD | — | +33.73% |
| 1 year | — | +32.20% |
| 3 years (CAGR) | — | +30.70% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | — | +31.83% |
Risk
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | — | 15.8% |
| Downside volatility | — | 8.5% |
| Sharpe | — | 1.53 |
| Sortino | — | 2.86 |
| Calmar | — | 2.06 |
| Return / risk | — | 1.95 |
| Deepest fall | — | −14.91% |
| Days to recover | — | 126 |
| Below its high | — | 0.00% |
Against benchmark
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.32% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 108.5% |
| Down capture | — | 71.5% |
| Tracking error | — | 6.1% |
| Information ratio | — | 1.13 |
| Treynor | — | 0.24 |
Consistency
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | — | +67.01% |
| Middle 1-year | — | +23.25% |
| Worst 1-year | — | +1.71% |
| 1-year periods with a loss | — | 0.0% |
| Middle 3-year | — | +30.22% |
| Positive months | — | 72.2% |
| Best day | — | +3.18% |
| Worst day | — | −3.61% |
| Worst 5% day | — | −1.51% |
| Positive days | — | 58.3% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata Banking & Financial Services Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | +27.71% |
| 1-year XIRR | — | +41.37% |
Holdings overlap i
Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
- HDFC Pharma and Healthcare Fund: no monthly portfolio filing is loaded, so it is left out here. HDFC Mutual Fund's website blocks automatic downloads, so its monthly file has to be added by hand and none is loaded yet.